Recruiting NA Neurologic Disorder

Compares treatment options for Neurologic Disorder

Official title Tele-reha Versus Paper-based Aftercare Programme Following Inpatient Rehabilitation

ClinicalTrials.gov ID: NCT05940584

What this study is testing

What it's testing
The goal of this three-armed, observer-blinded, randomised controlled trial is to (i) to implement a telerehabilitation intervention in routine care after an inpatient rehabilitation stay for people insured with the Social Insurance Institution for the Self-Employed (SVS), (ii) to evaluate the impact of telerehabilitation on the consolidation of goals achieved during the inpatient stay in everyday life, and (iii) to evaluate whether independence in everyday life can be increased by implementing telerehabilitation at home compared to standard care. Our hypothesis is that the tele-reha intervention, including ongoing therapist support, will improve independence in daily living (defined as the primary outcome of this study), as measured by the Functional Assessment Measure (FAM), compared to a control group receiving a standard paper-based program.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 99

You may be able to join if

  • aged 18 years or older,
  • experiencing problems with motor function, sensory function, cognition, swallowing or speech production (regardless of their diagnosis),
  • being insured with SVS,
  • agreeing to telerehabilitation after discharge,
  • having sufficient motor and cognitive abilities to operate a smartphone, tablet or PC, or being sufficiently supported by caregivers, and

You likely can't join if

  • \- pronounced impairments in awareness, memory, attention, spatial performance, executive performance, apraxia, speech, and visual perception that do...
See the full eligibility criteria
Who can join
  • aged 18 years or older,
  • experiencing problems with motor function, sensory function, cognition, swallowing or speech production (regardless of their diagnosis),
  • being insured with SVS,
  • agreeing to telerehabilitation after discharge,
  • having sufficient motor and cognitive abilities to operate a smartphone, tablet or PC, or being sufficiently supported by caregivers, and
  • being able to independently perform the targeted tasks assigned to them.
What rules you out
  • \- pronounced impairments in awareness, memory, attention, spatial performance, executive performance, apraxia, speech, and visual perception that do not allow a safe study participation according to the treating...

The study team makes the final eligibility decision.

Where it's taking place

  • Vienna, State of Vienna, Austria

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Vienna, State of Vienna, Austria. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.